AO RESEARCH · 2026.10.03
Industry research & source archive
Explore statistics, financial evidence, events, participation surveys, procurement and venue services, with original dates, units, regions and any scope that still needs confirmation.
Evidence counts do not represent new products, legal entities or accepted index samples. Source publication, scoring and image approvals remain unchanged.
Research briefs & report
Conditional specification research: select one identity
7 heterogeneous research identities and 70 source observations; displayed separately, without adding products or treating them as 70 homogeneous scalar parameters.
Topics support research navigation, not accepted object classification. Sources, units, dates and conflicts remain explicit; no new products or legal entities.
Financial Observations
100 records · 1 / 5
Source version & integrity
SHA-256 fe4e47549917b5cb1d345e31653743d2adc0d4134c5ff1e1828c8097d6f65cb5
The original source version is retained for verification.
Source record 1
- issuer legal name
- 舒华体育股份有限公司
- entity scope
- consolidated legal issuer group
- Period start
- 2024-01-01
- Period end
- 2024-12-31
- Period type
- fiscal_year
- Year
- 2024
- Metric
- revenue_total
- Reported metric
- 营业收入
- Printed number
- 1,417,094,638.60
- Reported unit
- 元(人民币)
- normalization factor
- 1
- Converted value
- 1417094638.60
- Converted unit
- CNY
- display value source units
- 1417094638.60
- Statistical scope
- consolidated issuer
- dimension
- — Not disclosed
- Source status
- canonical
- Missing-value reason
- — Not disclosed
- PDF page
- 6
- Printed page
- 6
- Original URL
- Open original source ↗
- access utc
- 2026-10-03T11:10:45.592311+00:00
- access window utc
- — Not disclosed
- evidence capture
- captures/shuhua_2024_revised_p006.png
- additional evidence
- PDF page
- 6
- Printed page
- 6
- role
- superseded original table amount agreement for curated scope only
- restatement scope
- 2024 revised edition selected; 2025 revenue/R&D comparatives agree; no adjustment to these consolidated totals detected. Curated 2024 revenue, R&D and MD&A category amounts checked against the superseded original and unchanged; overall reason for revised publication not independently established.
- continuing operations scope
- Terminated operations marked not applicable: EQ-S001 p199; EQ-S002 p196
- notes
- — Not disclosed
- Eligible for formal public use
- No
- Eligible for formal scoring
- No
- latest Mac597 dedup status
- pending current ledger absent
- v3 exact amount candidates
- — Not disclosed
- v3 fact status
- new financial observation not in v3 structured claims
- v3 fact check note
- Checked fixed v3 structured candidate JSON; same document already counted as source does not mean financial fact was already extracted. Low-information zeros/ratios checked by issuer/period/metric context, not token matching.
Source record 2
- issuer legal name
- 舒华体育股份有限公司
- entity scope
- consolidated legal issuer group
- Period start
- 2024-01-01
- Period end
- 2024-12-31
- Period type
- fiscal_year
- Year
- 2024
- Metric
- rd_expense
- Reported metric
- 研发费用
- Printed number
- 43,673,742.07
- Reported unit
- 元(人民币)
- normalization factor
- 1
- Converted value
- 43673742.07
- Converted unit
- CNY
- display value source units
- 43673742.07
- Statistical scope
- consolidated issuer
- dimension
- — Not disclosed
- Source status
- canonical
- Missing-value reason
- — Not disclosed
- PDF page
- 24
- Printed page
- 24
- Original URL
- Open original source ↗
- access utc
- 2026-10-03T11:10:45.592311+00:00
- access window utc
- — Not disclosed
- evidence capture
- captures/shuhua_2024_revised_p024.png
- additional evidence
- PDF page
- 24
- Printed page
- 24
- role
- superseded original table amount agreement for curated scope only
- restatement scope
- 2024 revised edition selected; 2025 revenue/R&D comparatives agree; no adjustment to these consolidated totals detected. Curated 2024 revenue, R&D and MD&A category amounts checked against the superseded original and unchanged; overall reason for revised publication not independently established.
- continuing operations scope
- Terminated operations marked not applicable: EQ-S001 p199; EQ-S002 p196
- notes
- Income statement expense; independently distinguished from total R&D input even where amounts match
- Eligible for formal public use
- No
- Eligible for formal scoring
- No
- latest Mac597 dedup status
- pending current ledger absent
- v3 exact amount candidates
- — Not disclosed
- v3 fact status
- new financial observation not in v3 structured claims
- v3 fact check note
- Checked fixed v3 structured candidate JSON; same document already counted as source does not mean financial fact was already extracted. Low-information zeros/ratios checked by issuer/period/metric context, not token matching.
Source record 3
- issuer legal name
- 舒华体育股份有限公司
- entity scope
- consolidated legal issuer group
- Period start
- 2024-01-01
- Period end
- 2024-12-31
- Period type
- fiscal_year
- Year
- 2024
- Metric
- rd_input_total
- Reported metric
- 研发投入合计
- Printed number
- 43,673,742.07
- Reported unit
- 元(人民币)
- normalization factor
- 1
- Converted value
- 43673742.07
- Converted unit
- CNY
- display value source units
- 43673742.07
- Statistical scope
- consolidated issuer
- dimension
- — Not disclosed
- Source status
- canonical
- Missing-value reason
- — Not disclosed
- PDF page
- 24
- Printed page
- 24
- Original URL
- Open original source ↗
- access utc
- 2026-10-03T11:10:45.592311+00:00
- access window utc
- — Not disclosed
- evidence capture
- captures/shuhua_2024_revised_p024.png
- additional evidence
- PDF page
- 24
- Printed page
- 24
- role
- superseded original table amount agreement for curated scope only
- restatement scope
- 2024 revised edition selected; 2025 revenue/R&D comparatives agree; no adjustment to these consolidated totals detected. Curated 2024 revenue, R&D and MD&A category amounts checked against the superseded original and unchanged; overall reason for revised publication not independently established.
- continuing operations scope
- Terminated operations marked not applicable: EQ-S001 p199; EQ-S002 p196
- notes
- Total R&D input as disclosed, not substituted from expense
- Eligible for formal public use
- No
- Eligible for formal scoring
- No
- latest Mac597 dedup status
- pending current ledger absent
- v3 exact amount candidates
- — Not disclosed
- v3 fact status
- new financial observation not in v3 structured claims
- v3 fact check note
- Checked fixed v3 structured candidate JSON; same document already counted as source does not mean financial fact was already extracted. Low-information zeros/ratios checked by issuer/period/metric context, not token matching.
Source record 4
- issuer legal name
- 舒华体育股份有限公司
- entity scope
- consolidated legal issuer group
- Period start
- 2024-01-01
- Period end
- 2024-12-31
- Period type
- fiscal_year
- Year
- 2024
- Metric
- rd_input_capitalized
- Reported metric
- 本期资本化研发投入
- Printed number
- 0.00
- Reported unit
- 元(人民币)
- normalization factor
- 1
- Converted value
- 0.00
- Converted unit
- CNY
- display value source units
- 0.00
- Statistical scope
- consolidated issuer
- dimension
- — Not disclosed
- Source status
- canonical
- Missing-value reason
- — Not disclosed
- PDF page
- 24
- Printed page
- 24
- Original URL
- Open original source ↗
- access utc
- 2026-10-03T11:10:45.592311+00:00
- access window utc
- — Not disclosed
- evidence capture
- captures/shuhua_2024_revised_p024.png
- additional evidence
- PDF page
- 24
- Printed page
- 24
- role
- superseded original table amount agreement for curated scope only
- restatement scope
- 2024 revised edition selected; 2025 revenue/R&D comparatives agree; no adjustment to these consolidated totals detected. Curated 2024 revenue, R&D and MD&A category amounts checked against the superseded original and unchanged; overall reason for revised publication not independently established.
- continuing operations scope
- Terminated operations marked not applicable: EQ-S001 p199; EQ-S002 p196
- notes
- — Not disclosed
- Eligible for formal public use
- No
- Eligible for formal scoring
- No
- latest Mac597 dedup status
- pending current ledger absent
- v3 exact amount candidates
- — Not disclosed
- v3 fact status
- new financial observation not in v3 structured claims
- v3 fact check note
- Checked fixed v3 structured candidate JSON; same document already counted as source does not mean financial fact was already extracted. Low-information zeros/ratios checked by issuer/period/metric context, not token matching.
Source record 5
- issuer legal name
- 舒华体育股份有限公司
- entity scope
- consolidated legal issuer group
- Period start
- 2024-01-01
- Period end
- 2024-12-31
- Period type
- fiscal_year
- Year
- 2024
- Metric
- rd_intensity_reported
- Reported metric
- 研发投入总额占营业收入比例(%)
- Printed number
- 3.08
- Reported unit
- %
- normalization factor
- 0.01
- Converted value
- 0.0308
- Converted unit
- ratio
- display value source units
- 3.08
- Statistical scope
- consolidated issuer
- dimension
- — Not disclosed
- Source status
- canonical
- Missing-value reason
- — Not disclosed
- PDF page
- 24
- Printed page
- 24
- Original URL
- Open original source ↗
- access utc
- 2026-10-03T11:10:45.592311+00:00
- access window utc
- — Not disclosed
- evidence capture
- captures/shuhua_2024_revised_p024.png
- additional evidence
- PDF page
- 24
- Printed page
- 24
- role
- superseded original table amount agreement for curated scope only
- restatement scope
- 2024 revised edition selected; 2025 revenue/R&D comparatives agree; no adjustment to these consolidated totals detected. Curated 2024 revenue, R&D and MD&A category amounts checked against the superseded original and unchanged; overall reason for revised publication not independently established.
- continuing operations scope
- Terminated operations marked not applicable: EQ-S001 p199; EQ-S002 p196
- notes
- Issuer rounded percentage; derived ratio stored separately
- Eligible for formal public use
- No
- Eligible for formal scoring
- No
- latest Mac597 dedup status
- pending current ledger absent
- v3 exact amount candidates
- — Not disclosed
- v3 fact status
- new financial observation not in v3 structured claims
- v3 fact check note
- Checked fixed v3 structured candidate JSON; same document already counted as source does not mean financial fact was already extracted. Low-information zeros/ratios checked by issuer/period/metric context, not token matching.
Source record 6
- issuer legal name
- 舒华体育股份有限公司
- entity scope
- consolidated legal issuer group
- Period start
- 2025-01-01
- Period end
- 2025-12-31
- Period type
- fiscal_year
- Year
- 2025
- Metric
- revenue_total
- Reported metric
- 营业收入
- Printed number
- 1,566,259,241.04
- Reported unit
- 元(人民币)
- normalization factor
- 1
- Converted value
- 1566259241.04
- Converted unit
- CNY
- display value source units
- 1566259241.04
- Statistical scope
- consolidated issuer
- dimension
- — Not disclosed
- Source status
- canonical
- Missing-value reason
- — Not disclosed
- PDF page
- 7
- Printed page
- 7
- Original URL
- Open original source ↗
- access utc
- 2026-10-03T11:08:10.246189+00:00
- access window utc
- — Not disclosed
- evidence capture
- captures/shuhua_2025_p007.png
- additional evidence
- — Not disclosed
- restatement scope
- 2024 revised edition selected; 2025 revenue/R&D comparatives agree; no adjustment to these consolidated totals detected. Curated 2024 revenue, R&D and MD&A category amounts checked against the superseded original and unchanged; overall reason for revised publication not independently established.
- continuing operations scope
- Terminated operations marked not applicable: EQ-S001 p199; EQ-S002 p196
- notes
- — Not disclosed
- Eligible for formal public use
- No
- Eligible for formal scoring
- No
- latest Mac597 dedup status
- pending current ledger absent
- v3 exact amount candidates
- — Not disclosed
- v3 fact status
- new financial observation not in v3 structured claims
- v3 fact check note
- Checked fixed v3 structured candidate JSON; same document already counted as source does not mean financial fact was already extracted. Low-information zeros/ratios checked by issuer/period/metric context, not token matching.
Source record 7
- issuer legal name
- 舒华体育股份有限公司
- entity scope
- consolidated legal issuer group
- Period start
- 2025-01-01
- Period end
- 2025-12-31
- Period type
- fiscal_year
- Year
- 2025
- Metric
- rd_expense
- Reported metric
- 研发费用
- Printed number
- 53,588,214.84
- Reported unit
- 元(人民币)
- normalization factor
- 1
- Converted value
- 53588214.84
- Converted unit
- CNY
- display value source units
- 53588214.84
- Statistical scope
- consolidated issuer
- dimension
- — Not disclosed
- Source status
- canonical
- Missing-value reason
- — Not disclosed
- PDF page
- 25
- Printed page
- 25
- Original URL
- Open original source ↗
- access utc
- 2026-10-03T11:08:10.246189+00:00
- access window utc
- — Not disclosed
- evidence capture
- captures/shuhua_2025_p025.png
- additional evidence
- — Not disclosed
- restatement scope
- 2024 revised edition selected; 2025 revenue/R&D comparatives agree; no adjustment to these consolidated totals detected. Curated 2024 revenue, R&D and MD&A category amounts checked against the superseded original and unchanged; overall reason for revised publication not independently established.
- continuing operations scope
- Terminated operations marked not applicable: EQ-S001 p199; EQ-S002 p196
- notes
- Income statement expense; independently distinguished from total R&D input even where amounts match
- Eligible for formal public use
- No
- Eligible for formal scoring
- No
- latest Mac597 dedup status
- pending current ledger absent
- v3 exact amount candidates
- — Not disclosed
- v3 fact status
- new financial observation not in v3 structured claims
- v3 fact check note
- Checked fixed v3 structured candidate JSON; same document already counted as source does not mean financial fact was already extracted. Low-information zeros/ratios checked by issuer/period/metric context, not token matching.
Source record 8
- issuer legal name
- 舒华体育股份有限公司
- entity scope
- consolidated legal issuer group
- Period start
- 2025-01-01
- Period end
- 2025-12-31
- Period type
- fiscal_year
- Year
- 2025
- Metric
- rd_input_total
- Reported metric
- 研发投入合计
- Printed number
- 53,588,214.84
- Reported unit
- 元(人民币)
- normalization factor
- 1
- Converted value
- 53588214.84
- Converted unit
- CNY
- display value source units
- 53588214.84
- Statistical scope
- consolidated issuer
- dimension
- — Not disclosed
- Source status
- canonical
- Missing-value reason
- — Not disclosed
- PDF page
- 26
- Printed page
- 26
- Original URL
- Open original source ↗
- access utc
- 2026-10-03T11:08:10.246189+00:00
- access window utc
- — Not disclosed
- evidence capture
- captures/shuhua_2025_p026.png
- additional evidence
- — Not disclosed
- restatement scope
- 2024 revised edition selected; 2025 revenue/R&D comparatives agree; no adjustment to these consolidated totals detected. Curated 2024 revenue, R&D and MD&A category amounts checked against the superseded original and unchanged; overall reason for revised publication not independently established.
- continuing operations scope
- Terminated operations marked not applicable: EQ-S001 p199; EQ-S002 p196
- notes
- Total R&D input as disclosed, not substituted from expense
- Eligible for formal public use
- No
- Eligible for formal scoring
- No
- latest Mac597 dedup status
- pending current ledger absent
- v3 exact amount candidates
- — Not disclosed
- v3 fact status
- new financial observation not in v3 structured claims
- v3 fact check note
- Checked fixed v3 structured candidate JSON; same document already counted as source does not mean financial fact was already extracted. Low-information zeros/ratios checked by issuer/period/metric context, not token matching.
Source record 9
- issuer legal name
- 舒华体育股份有限公司
- entity scope
- consolidated legal issuer group
- Period start
- 2025-01-01
- Period end
- 2025-12-31
- Period type
- fiscal_year
- Year
- 2025
- Metric
- rd_input_capitalized
- Reported metric
- 本期资本化研发投入
- Printed number
- 0.00
- Reported unit
- 元(人民币)
- normalization factor
- 1
- Converted value
- 0.00
- Converted unit
- CNY
- display value source units
- 0.00
- Statistical scope
- consolidated issuer
- dimension
- — Not disclosed
- Source status
- canonical
- Missing-value reason
- — Not disclosed
- PDF page
- 26
- Printed page
- 26
- Original URL
- Open original source ↗
- access utc
- 2026-10-03T11:08:10.246189+00:00
- access window utc
- — Not disclosed
- evidence capture
- captures/shuhua_2025_p026.png
- additional evidence
- — Not disclosed
- restatement scope
- 2024 revised edition selected; 2025 revenue/R&D comparatives agree; no adjustment to these consolidated totals detected. Curated 2024 revenue, R&D and MD&A category amounts checked against the superseded original and unchanged; overall reason for revised publication not independently established.
- continuing operations scope
- Terminated operations marked not applicable: EQ-S001 p199; EQ-S002 p196
- notes
- — Not disclosed
- Eligible for formal public use
- No
- Eligible for formal scoring
- No
- latest Mac597 dedup status
- pending current ledger absent
- v3 exact amount candidates
- — Not disclosed
- v3 fact status
- new financial observation not in v3 structured claims
- v3 fact check note
- Checked fixed v3 structured candidate JSON; same document already counted as source does not mean financial fact was already extracted. Low-information zeros/ratios checked by issuer/period/metric context, not token matching.
Source record 10
- issuer legal name
- 舒华体育股份有限公司
- entity scope
- consolidated legal issuer group
- Period start
- 2025-01-01
- Period end
- 2025-12-31
- Period type
- fiscal_year
- Year
- 2025
- Metric
- rd_intensity_reported
- Reported metric
- 研发投入总额占营业收入比例(%)
- Printed number
- 3.42
- Reported unit
- %
- normalization factor
- 0.01
- Converted value
- 0.0342
- Converted unit
- ratio
- display value source units
- 3.42
- Statistical scope
- consolidated issuer
- dimension
- — Not disclosed
- Source status
- canonical
- Missing-value reason
- — Not disclosed
- PDF page
- 26
- Printed page
- 26
- Original URL
- Open original source ↗
- access utc
- 2026-10-03T11:08:10.246189+00:00
- access window utc
- — Not disclosed
- evidence capture
- captures/shuhua_2025_p026.png
- additional evidence
- — Not disclosed
- restatement scope
- 2024 revised edition selected; 2025 revenue/R&D comparatives agree; no adjustment to these consolidated totals detected. Curated 2024 revenue, R&D and MD&A category amounts checked against the superseded original and unchanged; overall reason for revised publication not independently established.
- continuing operations scope
- Terminated operations marked not applicable: EQ-S001 p199; EQ-S002 p196
- notes
- Issuer rounded percentage; derived ratio stored separately
- Eligible for formal public use
- No
- Eligible for formal scoring
- No
- latest Mac597 dedup status
- pending current ledger absent
- v3 exact amount candidates
- — Not disclosed
- v3 fact status
- new financial observation not in v3 structured claims
- v3 fact check note
- Checked fixed v3 structured candidate JSON; same document already counted as source does not mean financial fact was already extracted. Low-information zeros/ratios checked by issuer/period/metric context, not token matching.
Source record 11
- issuer legal name
- 青岛英派斯健康科技股份有限公司
- entity scope
- consolidated legal issuer group
- Period start
- 2024-01-01
- Period end
- 2024-12-31
- Period type
- fiscal_year
- Year
- 2024
- Metric
- revenue_total
- Reported metric
- 营业收入
- Printed number
- 1,213,857,643.97
- Reported unit
- 元(人民币)
- normalization factor
- 1
- Converted value
- 1213857643.97
- Converted unit
- CNY
- display value source units
- 1213857643.97
- Statistical scope
- consolidated issuer
- dimension
- — Not disclosed
- Source status
- canonical
- Missing-value reason
- — Not disclosed
- PDF page
- 8
- Printed page
- 8
- Original URL
- Open original source ↗
- access utc
- 2026-10-03T11:09:47.328225+00:00
- access window utc
- — Not disclosed
- evidence capture
- captures/impulse_2024_p008.png
- additional evidence
- — Not disclosed
- restatement scope
- No retrospective adjustment/restatement selected in 2025 and 2024 main-indicator tables, both p8; 2024 monetary comparatives match.
- continuing operations scope
- Terminated-operation table blank in EQ-S003 p222; blank is not a numeric zero. Consolidated revenue taken as disclosed.
- notes
- — Not disclosed
- Eligible for formal public use
- No
- Eligible for formal scoring
- No
- latest Mac597 dedup status
- pending current ledger absent
- v3 exact amount candidates
- — Not disclosed
- v3 fact status
- new financial observation not in v3 structured claims
- v3 fact check note
- Checked fixed v3 structured candidate JSON; same document already counted as source does not mean financial fact was already extracted. Low-information zeros/ratios checked by issuer/period/metric context, not token matching.
Source record 12
- issuer legal name
- 青岛英派斯健康科技股份有限公司
- entity scope
- consolidated legal issuer group
- Period start
- 2024-01-01
- Period end
- 2024-12-31
- Period type
- fiscal_year
- Year
- 2024
- Metric
- rd_expense
- Reported metric
- 研发费用
- Printed number
- 52,552,467.25
- Reported unit
- 元(人民币)
- normalization factor
- 1
- Converted value
- 52552467.25
- Converted unit
- CNY
- display value source units
- 52552467.25
- Statistical scope
- consolidated issuer
- dimension
- — Not disclosed
- Source status
- canonical
- Missing-value reason
- — Not disclosed
- PDF page
- 30
- Printed page
- 30
- Original URL
- Open original source ↗
- access utc
- 2026-10-03T11:09:47.328225+00:00
- access window utc
- — Not disclosed
- evidence capture
- captures/impulse_2024_p030.png
- additional evidence
- — Not disclosed
- restatement scope
- No retrospective adjustment/restatement selected in 2025 and 2024 main-indicator tables, both p8; 2024 monetary comparatives match.
- continuing operations scope
- Terminated-operation table blank in EQ-S003 p222; blank is not a numeric zero. Consolidated revenue taken as disclosed.
- notes
- Income statement expense; independently distinguished from total R&D input even where amounts match
- Eligible for formal public use
- No
- Eligible for formal scoring
- No
- latest Mac597 dedup status
- pending current ledger absent
- v3 exact amount candidates
- — Not disclosed
- v3 fact status
- new financial observation not in v3 structured claims
- v3 fact check note
- Checked fixed v3 structured candidate JSON; same document already counted as source does not mean financial fact was already extracted. Low-information zeros/ratios checked by issuer/period/metric context, not token matching.
Source record 13
- issuer legal name
- 青岛英派斯健康科技股份有限公司
- entity scope
- consolidated legal issuer group
- Period start
- 2024-01-01
- Period end
- 2024-12-31
- Period type
- fiscal_year
- Year
- 2024
- Metric
- rd_input_total
- Reported metric
- 研发投入金额(元)
- Printed number
- 52,552,467.25
- Reported unit
- 元(人民币)
- normalization factor
- 1
- Converted value
- 52552467.25
- Converted unit
- CNY
- display value source units
- 52552467.25
- Statistical scope
- consolidated issuer
- dimension
- — Not disclosed
- Source status
- canonical
- Missing-value reason
- — Not disclosed
- PDF page
- 32
- Printed page
- 32
- Original URL
- Open original source ↗
- access utc
- 2026-10-03T11:09:47.328225+00:00
- access window utc
- — Not disclosed
- evidence capture
- captures/impulse_2024_p032.png
- additional evidence
- — Not disclosed
- restatement scope
- No retrospective adjustment/restatement selected in 2025 and 2024 main-indicator tables, both p8; 2024 monetary comparatives match.
- continuing operations scope
- Terminated-operation table blank in EQ-S003 p222; blank is not a numeric zero. Consolidated revenue taken as disclosed.
- notes
- Total R&D input as disclosed, not substituted from expense
- Eligible for formal public use
- No
- Eligible for formal scoring
- No
- latest Mac597 dedup status
- pending current ledger absent
- v3 exact amount candidates
- — Not disclosed
- v3 fact status
- new financial observation not in v3 structured claims
- v3 fact check note
- Checked fixed v3 structured candidate JSON; same document already counted as source does not mean financial fact was already extracted. Low-information zeros/ratios checked by issuer/period/metric context, not token matching.
Source record 14
- issuer legal name
- 青岛英派斯健康科技股份有限公司
- entity scope
- consolidated legal issuer group
- Period start
- 2024-01-01
- Period end
- 2024-12-31
- Period type
- fiscal_year
- Year
- 2024
- Metric
- rd_input_capitalized
- Reported metric
- 研发投入资本化的金额(元)
- Printed number
- 0.00
- Reported unit
- 元(人民币)
- normalization factor
- 1
- Converted value
- 0.00
- Converted unit
- CNY
- display value source units
- 0.00
- Statistical scope
- consolidated issuer
- dimension
- — Not disclosed
- Source status
- canonical
- Missing-value reason
- — Not disclosed
- PDF page
- 32
- Printed page
- 32
- Original URL
- Open original source ↗
- access utc
- 2026-10-03T11:09:47.328225+00:00
- access window utc
- — Not disclosed
- evidence capture
- captures/impulse_2024_p032.png
- additional evidence
- — Not disclosed
- restatement scope
- No retrospective adjustment/restatement selected in 2025 and 2024 main-indicator tables, both p8; 2024 monetary comparatives match.
- continuing operations scope
- Terminated-operation table blank in EQ-S003 p222; blank is not a numeric zero. Consolidated revenue taken as disclosed.
- notes
- — Not disclosed
- Eligible for formal public use
- No
- Eligible for formal scoring
- No
- latest Mac597 dedup status
- pending current ledger absent
- v3 exact amount candidates
- — Not disclosed
- v3 fact status
- new financial observation not in v3 structured claims
- v3 fact check note
- Checked fixed v3 structured candidate JSON; same document already counted as source does not mean financial fact was already extracted. Low-information zeros/ratios checked by issuer/period/metric context, not token matching.
Source record 15
- issuer legal name
- 青岛英派斯健康科技股份有限公司
- entity scope
- consolidated legal issuer group
- Period start
- 2024-01-01
- Period end
- 2024-12-31
- Period type
- fiscal_year
- Year
- 2024
- Metric
- rd_intensity_reported
- Reported metric
- 研发投入占营业收入比例
- Printed number
- 4.33%
- Reported unit
- %
- normalization factor
- 0.01
- Converted value
- 0.0433
- Converted unit
- ratio
- display value source units
- 4.33
- Statistical scope
- consolidated issuer
- dimension
- — Not disclosed
- Source status
- canonical
- Missing-value reason
- — Not disclosed
- PDF page
- 32
- Printed page
- 32
- Original URL
- Open original source ↗
- access utc
- 2026-10-03T11:09:47.328225+00:00
- access window utc
- — Not disclosed
- evidence capture
- captures/impulse_2024_p032.png
- additional evidence
- — Not disclosed
- restatement scope
- No retrospective adjustment/restatement selected in 2025 and 2024 main-indicator tables, both p8; 2024 monetary comparatives match.
- continuing operations scope
- Terminated-operation table blank in EQ-S003 p222; blank is not a numeric zero. Consolidated revenue taken as disclosed.
- notes
- Issuer rounded percentage; derived ratio stored separately
- Eligible for formal public use
- No
- Eligible for formal scoring
- No
- latest Mac597 dedup status
- pending current ledger absent
- v3 exact amount candidates
- — Not disclosed
- v3 fact status
- new financial observation not in v3 structured claims
- v3 fact check note
- Checked fixed v3 structured candidate JSON; same document already counted as source does not mean financial fact was already extracted. Low-information zeros/ratios checked by issuer/period/metric context, not token matching.
Source record 16
- issuer legal name
- 青岛英派斯健康科技股份有限公司
- entity scope
- consolidated legal issuer group
- Period start
- 2025-01-01
- Period end
- 2025-12-31
- Period type
- fiscal_year
- Year
- 2025
- Metric
- revenue_total
- Reported metric
- 营业收入
- Printed number
- 1,175,906,664.10
- Reported unit
- 元(人民币)
- normalization factor
- 1
- Converted value
- 1175906664.10
- Converted unit
- CNY
- display value source units
- 1175906664.10
- Statistical scope
- consolidated issuer
- dimension
- — Not disclosed
- Source status
- canonical
- Missing-value reason
- — Not disclosed
- PDF page
- 8
- Printed page
- 8
- Original URL
- Open original source ↗
- access utc
- — Not disclosed
- access window utc
- 2026-10-03T11:00:30Z
- 2026-10-03T11:03:00Z
- evidence capture
- captures/impulse_2025_p008.png
- additional evidence
- — Not disclosed
- restatement scope
- No retrospective adjustment/restatement selected in 2025 and 2024 main-indicator tables, both p8; 2024 monetary comparatives match.
- continuing operations scope
- Terminated-operation table blank in EQ-S003 p222; blank is not a numeric zero. Consolidated revenue taken as disclosed.
- notes
- — Not disclosed
- Eligible for formal public use
- No
- Eligible for formal scoring
- No
- latest Mac597 dedup status
- pending current ledger absent
- v3 exact amount candidates
- — Not disclosed
- v3 fact status
- new financial observation not in v3 structured claims
- v3 fact check note
- Checked fixed v3 structured candidate JSON; same document already counted as source does not mean financial fact was already extracted. Low-information zeros/ratios checked by issuer/period/metric context, not token matching.
Source record 17
- issuer legal name
- 青岛英派斯健康科技股份有限公司
- entity scope
- consolidated legal issuer group
- Period start
- 2025-01-01
- Period end
- 2025-12-31
- Period type
- fiscal_year
- Year
- 2025
- Metric
- rd_expense
- Reported metric
- 研发费用
- Printed number
- 51,565,452.91
- Reported unit
- 元(人民币)
- normalization factor
- 1
- Converted value
- 51565452.91
- Converted unit
- CNY
- display value source units
- 51565452.91
- Statistical scope
- consolidated issuer
- dimension
- — Not disclosed
- Source status
- canonical
- Missing-value reason
- — Not disclosed
- PDF page
- 28
- Printed page
- 28
- Original URL
- Open original source ↗
- access utc
- — Not disclosed
- access window utc
- 2026-10-03T11:00:30Z
- 2026-10-03T11:03:00Z
- evidence capture
- captures/impulse_2025_p028.png
- additional evidence
- — Not disclosed
- restatement scope
- No retrospective adjustment/restatement selected in 2025 and 2024 main-indicator tables, both p8; 2024 monetary comparatives match.
- continuing operations scope
- Terminated-operation table blank in EQ-S003 p222; blank is not a numeric zero. Consolidated revenue taken as disclosed.
- notes
- Income statement expense; independently distinguished from total R&D input even where amounts match
- Eligible for formal public use
- No
- Eligible for formal scoring
- No
- latest Mac597 dedup status
- pending current ledger absent
- v3 exact amount candidates
- — Not disclosed
- v3 fact status
- new financial observation not in v3 structured claims
- v3 fact check note
- Checked fixed v3 structured candidate JSON; same document already counted as source does not mean financial fact was already extracted. Low-information zeros/ratios checked by issuer/period/metric context, not token matching.
Source record 18
- issuer legal name
- 青岛英派斯健康科技股份有限公司
- entity scope
- consolidated legal issuer group
- Period start
- 2025-01-01
- Period end
- 2025-12-31
- Period type
- fiscal_year
- Year
- 2025
- Metric
- rd_input_total
- Reported metric
- 研发投入金额(元)
- Printed number
- 51,565,452.91
- Reported unit
- 元(人民币)
- normalization factor
- 1
- Converted value
- 51565452.91
- Converted unit
- CNY
- display value source units
- 51565452.91
- Statistical scope
- consolidated issuer
- dimension
- — Not disclosed
- Source status
- canonical
- Missing-value reason
- — Not disclosed
- PDF page
- 29
- Printed page
- 29
- Original URL
- Open original source ↗
- access utc
- — Not disclosed
- access window utc
- 2026-10-03T11:00:30Z
- 2026-10-03T11:03:00Z
- evidence capture
- captures/impulse_2025_p029.png
- additional evidence
- — Not disclosed
- restatement scope
- No retrospective adjustment/restatement selected in 2025 and 2024 main-indicator tables, both p8; 2024 monetary comparatives match.
- continuing operations scope
- Terminated-operation table blank in EQ-S003 p222; blank is not a numeric zero. Consolidated revenue taken as disclosed.
- notes
- Total R&D input as disclosed, not substituted from expense
- Eligible for formal public use
- No
- Eligible for formal scoring
- No
- latest Mac597 dedup status
- pending current ledger absent
- v3 exact amount candidates
- — Not disclosed
- v3 fact status
- new financial observation not in v3 structured claims
- v3 fact check note
- Checked fixed v3 structured candidate JSON; same document already counted as source does not mean financial fact was already extracted. Low-information zeros/ratios checked by issuer/period/metric context, not token matching.
Source record 19
- issuer legal name
- 青岛英派斯健康科技股份有限公司
- entity scope
- consolidated legal issuer group
- Period start
- 2025-01-01
- Period end
- 2025-12-31
- Period type
- fiscal_year
- Year
- 2025
- Metric
- rd_input_capitalized
- Reported metric
- 研发投入资本化的金额(元)
- Printed number
- 0.00
- Reported unit
- 元(人民币)
- normalization factor
- 1
- Converted value
- 0.00
- Converted unit
- CNY
- display value source units
- 0.00
- Statistical scope
- consolidated issuer
- dimension
- — Not disclosed
- Source status
- canonical
- Missing-value reason
- — Not disclosed
- PDF page
- 29
- Printed page
- 29
- Original URL
- Open original source ↗
- access utc
- — Not disclosed
- access window utc
- 2026-10-03T11:00:30Z
- 2026-10-03T11:03:00Z
- evidence capture
- captures/impulse_2025_p029.png
- additional evidence
- — Not disclosed
- restatement scope
- No retrospective adjustment/restatement selected in 2025 and 2024 main-indicator tables, both p8; 2024 monetary comparatives match.
- continuing operations scope
- Terminated-operation table blank in EQ-S003 p222; blank is not a numeric zero. Consolidated revenue taken as disclosed.
- notes
- — Not disclosed
- Eligible for formal public use
- No
- Eligible for formal scoring
- No
- latest Mac597 dedup status
- pending current ledger absent
- v3 exact amount candidates
- — Not disclosed
- v3 fact status
- new financial observation not in v3 structured claims
- v3 fact check note
- Checked fixed v3 structured candidate JSON; same document already counted as source does not mean financial fact was already extracted. Low-information zeros/ratios checked by issuer/period/metric context, not token matching.
Source record 20
- issuer legal name
- 青岛英派斯健康科技股份有限公司
- entity scope
- consolidated legal issuer group
- Period start
- 2025-01-01
- Period end
- 2025-12-31
- Period type
- fiscal_year
- Year
- 2025
- Metric
- rd_intensity_reported
- Reported metric
- 研发投入占营业收入比例
- Printed number
- 4.39%
- Reported unit
- %
- normalization factor
- 0.01
- Converted value
- 0.0439
- Converted unit
- ratio
- display value source units
- 4.39
- Statistical scope
- consolidated issuer
- dimension
- — Not disclosed
- Source status
- canonical
- Missing-value reason
- — Not disclosed
- PDF page
- 29
- Printed page
- 29
- Original URL
- Open original source ↗
- access utc
- — Not disclosed
- access window utc
- 2026-10-03T11:00:30Z
- 2026-10-03T11:03:00Z
- evidence capture
- captures/impulse_2025_p029.png
- additional evidence
- — Not disclosed
- restatement scope
- No retrospective adjustment/restatement selected in 2025 and 2024 main-indicator tables, both p8; 2024 monetary comparatives match.
- continuing operations scope
- Terminated-operation table blank in EQ-S003 p222; blank is not a numeric zero. Consolidated revenue taken as disclosed.
- notes
- Issuer rounded percentage; derived ratio stored separately
- Eligible for formal public use
- No
- Eligible for formal scoring
- No
- latest Mac597 dedup status
- pending current ledger absent
- v3 exact amount candidates
- — Not disclosed
- v3 fact status
- new financial observation not in v3 structured claims
- v3 fact check note
- Checked fixed v3 structured candidate JSON; same document already counted as source does not mean financial fact was already extracted. Low-information zeros/ratios checked by issuer/period/metric context, not token matching.

